These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25428258)

  • 1. Exploring the impact of drug properties on the extent of intestinal lymphatic transport - in vitro and in vivo studies.
    Lawless E; Griffin BT; O'Mahony A; O'Driscoll CM
    Pharm Res; 2015 May; 32(5):1817-29. PubMed ID: 25428258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model.
    Griffin BT; O'Driscoll CM
    J Pharm Pharmacol; 2006 Jul; 58(7):917-25. PubMed ID: 16805951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An examination of the effect of intestinal first pass extraction on intestinal lymphatic transport of saquinavir in the rat.
    Griffin BT; O'Driscoll CM
    Pharm Res; 2008 May; 25(5):1125-33. PubMed ID: 17975709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of intestinal lymphatic transport on the systemic exposure and brain deposition of a novel highly lipophilic compound with structural similarity to cholesterol.
    Caliph SM; Faassen FW; Porter CJ
    J Pharm Pharmacol; 2014 Oct; 66(10):1377-87. PubMed ID: 24821499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the intestinal lymphatics in the absorption of two highly lipophilic cholesterol ester transfer protein inhibitors (CP524,515 and CP532,623).
    Trevaskis NL; McEvoy CL; McIntosh MP; Edwards GA; Shanker RM; Charman WN; Porter CJ
    Pharm Res; 2010 May; 27(5):878-93. PubMed ID: 20221896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hypertriglyceridemia promotes intestinal lymphatic lipid and drug transport: a positive feedback mechanism in lipid and drug absorption.
    Trevaskis NL; Charman WN; Porter CJ
    Mol Pharm; 2011 Aug; 8(4):1132-9. PubMed ID: 21604764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive Triglyceride Turnover into the Mesenteric Lymph Is Unable to Support Efficient Lymphatic Transport of a Biomimetic Triglyceride Prodrug.
    Han S; Hu L; Quach T; Simpson JS; Trevaskis NL; Porter CJH
    J Pharm Sci; 2016 Feb; 105(2):786-796. PubMed ID: 26540595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability.
    Gershkovich P; Hoffman A
    Eur J Pharm Sci; 2005 Dec; 26(5):394-404. PubMed ID: 16140514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats.
    Caliph SM; Charman WN; Porter CJ
    J Pharm Sci; 2000 Aug; 89(8):1073-84. PubMed ID: 10906731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies.
    Han S; Quach T; Hu L; Wahab A; Charman WN; Stella VJ; Trevaskis NL; Simpson JS; Porter CJ
    J Control Release; 2014 Mar; 177():1-10. PubMed ID: 24398334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of triglyceride-rich lipoprotein secretion by polysorbate 80: in vitro and in vivo correlation using Caco-2 cells and a cannulated rat intestinal lymphatic model.
    Seeballuck F; Lawless E; Ashford MB; O'Driscoll CM
    Pharm Res; 2004 Dec; 21(12):2320-6. PubMed ID: 15648264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing Linker Chain Length and Intestinal Stability Enhances Lymphatic Transport and Lymph Node Exposure of Triglyceride Mimetic Prodrugs of a Model Immunomodulator Mycophenolic Acid.
    Han S; Quach T; Hu L; Lim SF; Zheng D; Leong NJ; Sharma G; Bonner D; Simpson JS; Trevaskis NL; Porter CJH
    Mol Pharm; 2023 May; 20(5):2675-2685. PubMed ID: 36996486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of lycopene in the rat: the role of intestinal lymphatic transport.
    Faisal W; O'Driscoll CM; Griffin BT
    J Pharm Pharmacol; 2010 Mar; 62(3):323-31. PubMed ID: 20487215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lymph lipid precursor pool is a key determinant of intestinal lymphatic drug transport.
    Trevaskis NL; Porter CJ; Charman WN
    J Pharmacol Exp Ther; 2006 Feb; 316(2):881-91. PubMed ID: 16249368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different impacts of intestinal lymphatic transport on the oral bioavailability of structurally similar synthetic lipophilic cannabinoids: dexanabinol and PRS-211,220.
    Gershkovich P; Qadri B; Yacovan A; Amselem S; Hoffman A
    Eur J Pharm Sci; 2007 Aug; 31(5):298-305. PubMed ID: 17560096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new function of Vitamin E-TPGS in the intestinal lymphatic transport of lipophilic drugs: enhancing the secretion of chylomicrons.
    Fan Z; Wu J; Fang X; Sha X
    Int J Pharm; 2013 Mar; 445(1-2):141-7. PubMed ID: 23396256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic transport of orally administered probucol-loaded mPEG-DSPE micelles.
    Han L; Yang Q; Shen T; Qing J; Wang J
    Drug Deliv; 2016 Jul; 23(6):1955-61. PubMed ID: 25816053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of cellular uptake, transport and oral absorption of protease inhibitor saquinavir by nanocrystal formulation.
    He Y; Xia DN; Li QX; Tao JS; Gan Y; Wang C
    Acta Pharmacol Sin; 2015 Sep; 36(9):1151-60. PubMed ID: 26256404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mesenteric lymph duct cannulated rat model: application to the assessment of intestinal lymphatic drug transport.
    Trevaskis NL; Hu L; Caliph SM; Han S; Porter CJ
    J Vis Exp; 2015 Mar; (97):. PubMed ID: 25866901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structured triglyceride vehicles for oral delivery of halofantrine: examination of intestinal lymphatic transport and bioavailability in conscious rats.
    Holm R; Porter CJ; Müllertz A; Kristensen HG; Charman WN
    Pharm Res; 2002 Sep; 19(9):1354-61. PubMed ID: 12403073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.